Applied DNA Sciences shares are trading lower. The company announced it received a subcontract award from LRQA for a pilot isotopic testing program.
Portfolio Pulse from Benzinga Newsdesk
Applied DNA Sciences shares are trading lower following the announcement of a subcontract award from LRQA for a pilot isotopic testing program.

September 04, 2024 | 7:34 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Applied DNA Sciences shares are experiencing a decline after the company announced a subcontract award from LRQA for a pilot isotopic testing program.
The announcement of a subcontract award typically indicates a positive development, but the market's reaction suggests that investors may have had higher expectations or concerns about the financial impact of the pilot program. This has led to a short-term decline in the stock price.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 100